DCOYDecoy Therapeutics Inc. Common Stock
3.200USD-6.16%Mkt Cap: 2.10M $P/E: 0.033d ago
Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company. It focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (I…